ROM1

ROM1 stands for retinal outer segment membrane protein 1. The protein it makes is anchored at the rim of the photoreceptor (definition: A light-sensing cell in the retina. Rods (used for night and peripheral vision) and cones (used for color and detail) are the two types.) disks — the stacked, membrane-lined structures that give rod and cone cells their light-catching outer segments. ROM1 does not usually act alone; it joins with copies of itself or with PRPH2 (also known as RDS) to form the building blocks of these disks. ROM1 and PRPH2 are so alike because their genes descended from a shared ancestral gene, which gives them similar structures and overlapping jobs. In laboratory mice, the correct pairing of these two proteins is essential for photoreceptor outer segments to form at all.

Because ROM1 helps keep photoreceptor (definition: A light-sensing cell in the retina. Rods (used for night and peripheral vision) and cones (used for color and detail) are the two types.) outer segments intact, changes in the gene can gradually undermine the cells that convert light into vision. In the two published cases of retinal dystrophy caused by two ROM1 changes, both people were in their sixties before their vision problems were recognized, and both kept relatively good central sharpness. Their retinas showed scattered pale flecks with relative sparing of the very center of the macula, a pattern that can look similar to disease caused by PRPH2 or ABCA4. Because of that overlap, ROM1-related disease can be mistaken for other retinal conditions unless genetic testing is done. Symptoms, age of onset, and how quickly vision changes all vary from person to person, so no single course applies to everyone with a ROM1 result.

ROM1 and PRPH2 work as a team to shape and stabilize photoreceptor (definition: A light-sensing cell in the retina. Rods (used for night and peripheral vision) and cones (used for color and detail) are the two types.) disks, and this partnership is the central fact behind ROM1's role in retinal disease. The most established disease link is digenic: a person carries one change in ROM1 and one in PRPH2, and only the combination produces retinitis pigmentosa. ROM1 can also act as a modifier — an extra genetic change that makes disease driven mainly by another gene more severe. In one large family, adding a ROM1 change to a PRPH2 change worsened the retinal disease, and the people who carried changes in PRPH2, ROM1 and ABCA4 together were the most severely affected. In a large study comparing patients who had ABCA4/Stargardt disease with unaffected people, rare ROM1 variants were found more often in the patients, which supports a modifying role across more than one retinal condition. More recently, two separate reports have shown that inheriting two damaging ROM1 changes — one from each parent — can cause a late-onset retinal dystrophy without any PRPH2 change. A ROM1 duplication has also been reported in two unrelated families with retinitis pigmentosa.

How often ROM1 causes retinal disease entirely on its own remains unclear, and the authors of the biallelic case reports describe it as exceptionally rare. Telling harmful ROM1 changes apart from harmless natural variation has been difficult since the 1990s, when several rare ROM1 sequence changes were found that did not track cleanly with disease. ROM1's modifier effect is not universal either: in two families with variable PRPH2 disease, no ROM1 change was found to explain the differences. One laboratory study raised the possibility that ROM1 could be linked to abnormal blood-vessel growth in the retina, but this remains an untested hypothesis rather than a confirmed effect.

As of the date of this review, no treatment targeting ROM1 has been approved, and RP Hope's reviewed records do not identify a ROM1-specific therapy in testing. Much of the research on ROM1 aims to understand how it pairs with PRPH2, because that partnership is intricate and has made a single targeted therapy difficult to design. Studies in mice and in cultured cells have clarified how ROM1 and PRPH2 assemble, but these are laboratory findings, not treatments available to people.

• Why ROM1 and PRPH2 must pair correctly

  Animal (mouse) laboratory research.

  What was found:

  Covalently linked Prph2/Rom1 complexes were essential for outer segments to form, and rods and cones differed in how sensitive they were to changes in these complexes.

  Why it matters:

  It helps explain, at the level of retinal structure, why ROM1 matters for healthy photoreceptors.

  Limitation: Results are from mice and describe biology, not a treatment for people.

• Two ROM1 changes linked to late-onset retinal dystrophy

  Single human case report.

  What was found:

  A 62-year-old man with two damaging ROM1 changes had diffuse flecks across the retina but preserved central vision, and no PRPH2 change was found.

  Why it matters:

  It adds to the evidence that ROM1 changes on their own can cause retinal dystrophy, not only in combination with PRPH2.

  Limitation: Findings come from one patient, so they cannot describe the full range of ROM1 disease.

• Complete loss of ROM1 protein in a case of pattern macular dystrophy

  Single human case report.

  What was found:

  She carried a homozygous frameshift change predicted to eliminate ROM1 function, with hyperautofluorescent flecks and preserved acuity, and no changes in ABCA4, PRPH2, or other candidate genes.

  Why it matters:

  It was described as the first case of complete loss of ROM1 function and shows the phenotype can closely resemble ABCA4- and PRPH2-related disease.

  Limitation: A single patient limits how broadly the conclusions apply.

• ROM1 as a modifier of PRPH2 and ABCA4 disease within a family

  Observational human family study.

  What was found:

  All affected members carried a PRPH2 change; adding a ROM1 change made the disease more severe, and people carrying all three gene changes were the most severely affected.

  Why it matters:

  It illustrates how ROM1 can worsen disease that is mainly driven by another gene, which affects genetic counseling.

  Limitation: Based on a single family, so the size of the effect cannot be generalized.

• Rare ROM1 variants enriched in ABCA4/Stargardt patients

  Case-control cohort (statistical association).

  What was found:

  Rare, likely functional ROM1 variants were found more often in patients than in controls, and a common PRPH2 haplotype was also more frequent in patients.

  Why it matters:

  It supports the idea that ROM1 can modify the course of retinal disease across more than one condition.

  Limitation: The study shows association and infers mechanism; it does not prove ROM1 changes directly caused the differences.

ROM1 stands out from many retinal genes because its inheritance can be unusual. In the classic digenic pattern, disease appears only when a change in ROM1 is combined with a change in PRPH2, so a single ROM1 change on its own may cause no symptoms. In the rare cases where ROM1 acts alone, disease required two ROM1 changes — one inherited from each parent — which is a recessive pattern. These patterns make family testing and interpretation more complex than for a typical single-gene condition, so genetic counseling that looks at more than one gene is particularly valuable. The reported ROM1-driven disease also began later in life, which may be worth keeping in mind for relatives.

• Do my results show changes in ROM1 alone, or also in PRPH2 or another retinal gene?
• Does my result fit a digenic (two-gene) pattern, and what would that mean for me?
• Which type of retinal disease best matches my imaging and symptoms?
• How often would you recommend monitoring my retina?
• Could my particular ROM1 change be a harmless variant rather than a cause of disease?
• What does this result mean for testing my relatives?

Confirming exactly which ROM1 change or changes you carry — and whether a PRPH2 or other change is also present — can clarify what the result means. Because ROM1 disease is often tied to a second gene, a careful review of your full genetic report with a specialist is especially useful here. RP Hope's genetic testing resources explain what testing involves and what to ask a genetic counselor. A retinal specialist can use imaging to follow the retina over time and to distinguish ROM1-related disease from lookalike conditions.